LONDON, May 22, 2024
/PRNewswire/ -- Qinecsa Solutions (Qinecsa), specialists in
technology-led end-to-end pharmacovigilance solutions, will host an
expert discussion on post-marketing safety surveillance, diving
deeply into the intricate world of medical devices and drug-device
combination products. This expert-led online webinar will take
place Wednesday, May 29, 2024, with a
choice of three sessions.
In this second part online seminar, industry expert Veronika
Valdova will explore the reporting essentials and obligations
associated with the post-marketing safety surveillance of medical
devices and drug-device combination products in both the EU and
USA markets. This will build upon
the foundation set in an earlier online seminar, exploring key EU
regulatory requirements, integration challenges, and actionable
steps for building resilient processes to support combined drug and
device portfolios within primarily pharma-focused
organizations.
This online seminar will guide participants through current
trends and challenges in the industry, offering valuable insights
into best practices and regulatory expectations to navigate the
complexities of safety surveillance and ensure compliance with
international standards.
Participants will come away with a greater understanding
of:
- Drug-Device and Combination Products – both in Europe and the U.S.
- Reporting Essentials and Obligations
- Essential Procedures to Cover
- Comparison of Reporting Requirements in the EU vs the U.S.
- Current Trends and/or Challenges
- Best Practices
For more information on this free to attend Qinecsa webinar, and
to register, visit Webinar: Navigating Post-Marketing Safety
Surveillance - Qinecsa
Save the Date: Wednesday, May
29th.
- Session 1: 6am ET |
12pm CE
- Session 2: 10am ET |
4pm CET
- Session 3: 2pm ET |
8pm CET.
To connect with Qinecsa, visit www.qinecsa.com
About Qinecsa Solutions
Qinecsa are specialists in technology led end-to-end
pharmacovigilance solutions. We are trusted, global partners
bringing together best-in-class technology and scientific expertise
to connect life science companies to the right safety solutions.
Through our unique insight into the challenges of
pharmacovigilance, we have created industry-leading, end-to-end
solutions for capturing, managing, and evaluating drug safety data,
more efficiently and accurately. Working with life science
companies we drive progress to continue protecting lives.
For more information visit: www.qinecsa.com
View original
content:https://www.prnewswire.com/news-releases/qinecsa-host-industry-discussion-on-navigating-post-marketing-safety-surveillance-of-medical-devices-and-drug-device-combination-products-eu-and-usa-302152034.html
SOURCE Qinecsa